Kino Y
Chemo-Sero-Therapeutic Research Institute.
Nihon Rinsho. 2000 Nov;58(11):2307-12.
Inactivated influenza vaccine has been widely used; however, its effectiveness is not always perfect. To create a much better vaccine, live vaccines have been extensively investigated. Among several candidate live vaccines, cold-adapted(Ca) vaccine is the only promising candidate. According to clinical studies recently conducted in the U.S., Ca vaccine was proven to be highly effective against laboratory confirmed influenza, both in adults and children. Furthermore, Ca vaccines for the H5N1 pandemic strains were generated and their attenuation and efficacy were confirmed in experimental animals.
灭活流感疫苗已被广泛使用;然而,其效果并不总是完美的。为了研发出更好的疫苗,人们对活疫苗进行了广泛研究。在几种候选活疫苗中,冷适应(Ca)疫苗是唯一有前景的候选疫苗。根据美国最近进行的临床研究,Ca疫苗被证明对实验室确诊的流感在成人和儿童中都非常有效。此外,还研发出了针对H5N1大流行毒株的Ca疫苗,并在实验动物中证实了其减毒效果和效力。